Across TCGA pan-cancer cohorts, RN7SL413P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RN7SL413P data layer.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher RN7SL413P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RN7SL413P expression acts as an unfavorable survival marker, although some lineages such as COAD and ESCA show a favorable association.
COAD, THCA, and BLCA are the cancer types where RN7SL413P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.